非那雄胺与多沙唑嗪：良性前列腺增生症脂质调节作用的比较 - Suppr

Suppr

超能文献

Finasteride and Doxazosin: A Comparison of Lipid-Modulating Effects in Benign Prostatic Hyperplasia.

作者信息

Calaza Lauren, Wi Ryan, Torosoff Mikhail

机构信息

Albany Medical College, Albany, USA.

出版信息

Int Urol Nephrol. 2025 Apr 29. doi: 10.1007/s11255-025-04523-0.

DOI:10.1007/s11255-025-04523-0

PMID:40299183

Abstract

摘要

相似文献

Finasteride and Doxazosin: A Comparison of Lipid-Modulating Effects in Benign Prostatic Hyperplasia.非那雄胺与多沙唑嗪：良性前列腺增生症脂质调节作用的比较

Int Urol Nephrol. 2025 Apr 29. doi: 10.1007/s11255-025-04523-0.

Change in sexual function in men with lower urinary tract symptoms/benign prostatic hyperplasia associated with long-term treatment with doxazosin, finasteride and combined therapy.多沙唑嗪、非那雄胺长期治疗及联合治疗对伴有下尿路症状/良性前列腺增生男性性功能的影响

J Urol. 2014 Jun;191(6):1828-34. doi: 10.1016/j.juro.2013.12.014. Epub 2013 Dec 14.

The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.多沙唑嗪、非那雄胺及联合治疗对良性前列腺增生临床进展的长期影响。

N Engl J Med. 2003 Dec 18;349(25):2387-98. doi: 10.1056/NEJMoa030656.

The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia.多沙唑嗪、非那雄胺及联合治疗对良性前列腺增生男性夜尿症的影响。

J Urol. 2007 Nov;178(5):2045-50; discussion 2050-1. doi: 10.1016/j.juro.2007.07.013. Epub 2007 Sep 17.

Long-term effects of doxazosin, finasteride and combination therapy on quality of life in men with benign prostatic hyperplasia.多沙唑嗪、非那雄胺和联合治疗对良性前列腺增生症患者生活质量的长期影响。

J Urol. 2013 Jul;190(1):187-93. doi: 10.1016/j.juro.2013.01.061. Epub 2013 Jan 25.

Cost-Effectiveness of Combination Therapy Versus Monotherapy in Benign Prostatic Hyperplasia: A Colombian Experience.联合治疗与单一疗法治疗良性前列腺增生的成本效益：哥伦比亚的经验

Value Health Reg Issues. 2018 Dec;17:174-182. doi: 10.1016/j.vhri.2018.09.004. Epub 2018 Nov 8.

Time Course of Incident Adverse Experiences Associated with Doxazosin, Finasteride and Combination Therapy in Men with Benign Prostatic Hyperplasia: The MTOPS Trial.良性前列腺增生症男性中多沙唑嗪、非那雄胺和联合治疗相关不良事件的时间进程：MTOPS 试验。

J Urol. 2016 Jun;195(6):1825-9. doi: 10.1016/j.juro.2015.11.065. Epub 2015 Dec 8.

Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial.多沙唑嗪与非那雄胺单独或联合使用治疗有症状的良性前列腺增生的疗效和耐受性：欧洲多沙唑嗪前瞻性联合治疗（PREDICT）试验

Urology. 2003 Jan;61(1):119-26. doi: 10.1016/s0090-4295(02)02114-3.

Finasteride for benign prostatic hyperplasia.非那雄胺用于良性前列腺增生症。

Cochrane Database Syst Rev. 2010 Oct 6;2010(10):CD006015. doi: 10.1002/14651858.CD006015.pub3.

Combination of finasteride and doxazosin for the treatment of benign prostatic hyperplasia.非那雄胺与多沙唑嗪联合治疗良性前列腺增生症。

Expert Opin Pharmacother. 2004 May;5(5):1209-11. doi: 10.1517/14656566.5.5.1209.

本文引用的文献

Effect of different alpha-receptor antagonists on metabolic parameters: a head-to-head comparison.不同α受体拮抗剂对代谢参数的影响：头对头比较。

Int Urol Nephrol. 2024 Aug;56(8):2489-2494. doi: 10.1007/s11255-024-03968-z. Epub 2024 Mar 8.

Finasteride delays atherosclerosis progression in mice and is associated with a reduction in plasma cholesterol in men.非那雄胺可延缓小鼠动脉粥样硬化的进展，并与男性血浆胆固醇降低有关。

J Lipid Res. 2024 Mar;65(3):100507. doi: 10.1016/j.jlr.2024.100507. Epub 2024 Jan 23.

Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study.血清雌激素水平与前列腺癌预防试验中的前列腺癌风险：巢式病例对照研究。

Cancer Causes Control. 2011 Aug;22(8):1121-31. doi: 10.1007/s10552-011-9787-7. Epub 2011 Jun 11.

Effects of finasteride on serum testosterone and body mass index in men with benign prostatic hyperplasia.非那雄胺对良性前列腺增生男性血清睾酮和体重指数的影响。

Urology. 2003 Nov;62(5):894-9. doi: 10.1016/s0090-4295(03)00661-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验